Jay Ames
Family Medicine · Chesterton, INNPI 1538158134
Payments from drug & device makers
Across 59 payments — averaging $25.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$350
- Johnson & Johnson$209
- Neurelis, Inc.$186
- Vanda Pharmaceuticals Inc.$143
- GSK$139
- OWP Pharmaceuticals, Inc.$78
- plus $377 from 16 others
What the payments were for
- Food & beverage$1,46199%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $350 |
| Johnson & Johnson | 8 | $209 |
| Neurelis, Inc. | 6 | $186 |
| Vanda Pharmaceuticals Inc. | 6 | $143 |
| GSK | 4 | $139 |
| OWP Pharmaceuticals, Inc. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Lundbeck LLC | 2 | $43 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| Itamar Medical Inc | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Gilead | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Lucid Diagnostics Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Novartis | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$106
How this compares
$1,482 in reported general payments places this provider in the 65th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 13 | $16,142 |
| OzempicSemaglutide | 11 | $10,647 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $5,052 |
| Aripiprazole | 11 | $4,005 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $3,320 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 84 | $2,060 |
| Trazodone Hcl | 15 | $966 |
| Atorvastatin Calcium | 92 | $778 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $750 |
| Amlodipine Besylate | 113 | $740 |
| Levothyroxine Sodium | 54 | $721 |
| Olanzapine | 11 | $544 |
| Potassium Chloride | 20 | $533 |
| Oxcarbazepine | 18 | $523 |
| Omeprazole | 45 | $479 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Chesterton
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.